Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep;158(3):913-922.
doi: 10.1016/j.chest.2020.04.011. Epub 2020 Apr 21.

Prevention of Asthma: Targets for Intervention

Michelle C Maciag  1 , Wanda Phipatanakul  2
Affiliations
Review

Prevention of Asthma: Targets for Intervention

Michelle C Maciag et al. Chest. 2020 Sep.

Abstract

Approximately 300 million people worldwide are estimated to be affected by asthma, and the number of patients affected is growing exponentially-with potential for an additional 100 million people affected by the condition by 2025. With this increasing burden of disease, there is high motivation to discover effective prevention strategies. Strategies aimed at stalling the atopic progression, modifying the microbiome, preventing respiratory viral infections, and reducing the impact of toxin/pollutant exposure through dietary supplements have had limited success in the prevention of asthma. This is likely because asthma is heterogenous and is influenced by different genetic and environmental factors. Genes underlie a predisposition to asthma and allergic sensitization, whereas exposure to allergens, respiratory infections, and pollution may modify asthma pathogenesis and the variation in severity seen among individuals. Future advances in asthma prevention may include a more personalized approach: genetic variations among susceptible individuals with distinct asthma phenotypes or different biomarkers of disease may help individualize prevention strategies and render them more . In this article, we summarize interventions that have been studied for the prevention of asthma and identify some of the clinical trials that are actively underway in asthma prevention.

Keywords: asthma; immunotherapy; omalizumab; prevention; vitamin D.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Factors involved in asthma pathogenesis and attempted strategies at prevention.
See this image and copyright information in PMC

References

    1. Masoli M., Fabian D., Holt S., Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004;59(5):469–478. - PubMed
    1. Gur M., Hakim F., Bentur L. Better understanding of childhood asthma, towards primary prevention: are we there yet? Consideration of pertinent literature. F1000Res. 2017;6:2152. - PMC - PubMed
    1. McGeachie M.J., Yates K.P., Zhou X. Patterns of growth and decline in lung function in persistent childhood asthma. N Engl J Med. 2016;374(19):1842–1852. - PMC - PubMed
    1. Rhodes H.L., Sporik R., Thomas P., Holgate S.T., Cogswell J.J. Early life risk factors for adult asthma: a birth cohort study of subjects at risk. J Allergy Clin Immunol. 2001;108(5):720–725. - PubMed
    1. Beigelman A., Bacharier L.B. Early-life respiratory infections and asthma development: role in disease pathogenesis and potential targets for disease prevention. Curr Opin Allergy Clin Immunol. 2016;16(2):172–178. - PMC - PubMed

Publication types

MeSH terms